4737 logo

Bionime Corporation Stock Price

TWSE:4737 Community·NT$4.7b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

4737 Share Price Performance

NT$70.10
19.37 (38.17%)
NT$70.10
19.37 (38.17%)
Price NT$70.10

4737 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Good value with very low risk.

2 Risks
1 Reward

Bionime Corporation Key Details

NT$1.8b

Revenue

NT$1.2b

Cost of Revenue

NT$627.8m

Gross Profit

NT$808.1m

Other Expenses

-NT$180.3m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
-2.68
34.15%
-9.81%
133.1%
View Full Analysis

About 4737

Founded
2003
Employees
n/a
CEO
Chun-Mu Huang
WebsiteView website
www.bionime.com

Bionime Corporation designs, manufactures, and sells medical instruments in China, Switzerland, the United States, Belarus, Algeria, the United Arab Emirates, Egypt, and internationally. The company manufactures and sells blood glucose meters and test strips to medical equipment companies, pharmacies, and hospitals, as well as offers blood glucose monitoring devices and systems under the RIGHTEST brand; a continuous glucose monitoring system under the iFree CGM brand; and medical blood glucose management systems. It is also involved in the provision of biotechnology services; drug testing; examination of pharmaceutical products; and the sale of precision instruments. Bionime Corporation was incorporated in 2003 and is based in Taichung, Taiwan.

Recent 4737 News & Updates

Recent updates

No updates